BRKR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BRKR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Bruker's Accounts Payable for the quarter that ended in Mar. 2024 was $199 Mil.
Bruker's quarterly Accounts Payable increased from Sep. 2023 ($182 Mil) to Dec. 2023 ($203 Mil) but then declined from Dec. 2023 ($203 Mil) to Mar. 2024 ($199 Mil).
Bruker's annual Accounts Payable increased from Dec. 2021 ($147 Mil) to Dec. 2022 ($178 Mil) and increased from Dec. 2022 ($178 Mil) to Dec. 2023 ($203 Mil).
The historical data trend for Bruker's Accounts Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bruker Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Accounts Payable | Get a 7-Day Free Trial |
![]() |
![]() |
118.40 | 134.60 | 147.40 | 178.40 | 202.70 |
Bruker Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Accounts Payable | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
196.20 | 188.80 | 181.50 | 202.70 | 199.10 |
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
Thank you for viewing the detailed overview of Bruker's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Frank H Laukien | director, 10 percent owner, officer: CEO, President | C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821 |
Marc A Kastner | director | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Cynthia M Friend | director | C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Richard A Packer | director | 9 KENDALL DRIVE, WESTBOROUGH MA 01581 |
Philip Ma | director | C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Mark Munch | officer: Pres. Bruker Nano Inc. | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Juergen Srega | officer: Group President Bruker CALID | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Burkhard Prause | officer: Pres. & CEO, Bruker EST | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Bonnie H Anderson | director | 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080 |
Martin Gilles Gerard Jean | director | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Falko Busse | officer: President, BioSpin Group | 40 MANNING ROAD, BILLERICA MA 01821 |
Gerald N Herman | officer: Vice President, Corp Contr. | 55 EXECUTIVE DRIVE, HUDSON NH 03051 |
Ingen Chris Van | director | 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306 |
Richard Kniss | director | 395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306 |
Adelene Q Perkins | director | C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
From GuruFocus
By Business Wire • 08-14-2023
By Business Wire • 01-03-2024
By Business Wire Business Wire • 06-05-2023
By Business Wire • 07-25-2023
By Business Wire • 08-17-2023
By Business Wire • 10-27-2023
By Business Wire • 09-07-2023
By Business Wire • 08-03-2023
By Business Wire Business Wire • 06-14-2023
By GuruFocus Research • 11-22-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.